Skip to main navigation

01
Home
02
Science
03
Pipeline
04
Company
05
Investors & Media

Investors & Media

Overview
Press Releases
Events & Presentations
Stock Info
Governance
Financial Info
Investor Info

Events & Presentations

Presentations

Rein Therapeutics Corporate Presentation

January 21, 2026

Download

IPF Summit 2025: Innovating Clinical Trial Design in IPF: Lessons from LTI-03

August 21, 2025

Download

ATS 2025: Evaluating alveolar regenerative properties of caveolin-1 scaffolding domain (CSD) peptides in three dimensional (3D) alveolospheres from IPF and normal donor lungs

May 19, 2025

Download

ATS 2025: Pre-clinical Proof-of-concept of Anti-fibrotic Activity Of Caveolin-1 Scaffolding Domain Peptide LTI-03 In Ex Vivo Precision Cut Lung Slices From Patients With Idiopathic Pulmonary Fibrosis

May 19, 2025

Download

Rein Therapeutics Corporate Presentation

May 15, 2025

Download

LTI-03 Cohort 2 Data Call

November 13, 2024

Download

ICLAF 2024: Inhalation of LTI-03 modulates multiple targets in a Phase 1b placebo-controlled clinical trial for IPF

October 16, 2024

Download

ICLAF 2024: Anti-fibrotic activity of Caveolin-1 scaffolding domain peptide LTI-03 in IPF precision cut lung slices

October 16, 2024

Download

IPF Summit 2024: Biomarker Strategies in the Clinical Development of LTI-03 in IPF

August 21, 2024

Download

LTI-03 Data Call

May 1, 2024

Download

Clinical Perspectives on Treating IPF

February 15, 2024

Download

Merger Announcement

October 31, 2023

Download

Upcoming Events

More events are coming soon.

Past Events

Fresh Breath of Air in IPF: Rein Therapeutics' CEO joined a virtual fireside chat hosted by Jones Trading

July 14, 2025

Read More

The Citizens Life Sciences Conference 2025

May 8, 2025 12:00 PM EDT

Read More

LTI-03 Cohort 2 Data Call

November 13, 2024 8:30 AM EST

Read More

Science
Pipeline
Company
Investors & Media

Rein Therapeutics^TM 2026

Privacy Policy